Another monoclonal antibody, DC8E8, can inhibit extracellular tau–tau interactions, discriminate between healthy and pathological tau, reduce tau pathology in mouse tauopathy models, and inhibit internalization of extracellular pathogenic tau in AD neurons in vitro [110]. Here, MAPT is linked to tauopathy.